BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Qian C, Christensen E, Roche PC, Smith DI, Thibodeau SN. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling. Nat Genet 2000;26:146-7. [DOI: 10.1038/79859] [Cited by in Crossref: 337] [Cited by in F6Publishing: 326] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Sánchez-fidalgo S, Villegas I, Cárdeno A, Talero E, Sánchez-hidalgo M, Motilva V, Alarcón de la Lastra C. Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clinical Nutrition 2010;29:663-73. [DOI: 10.1016/j.clnu.2010.03.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
2 Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 2002;16:2058-72. [PMID: 12183361 DOI: 10.1101/gad.227502] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 6.7] [Reference Citation Analysis]
3 Howe LJ, Hemani G, Lesseur C, Gaborieau V, Ludwig KU, Mangold E, Brennan P, Ness AR, St Pourcain B, Davey Smith G, Lewis SJ. Evaluating shared genetic influences on nonsyndromic cleft lip/palate and oropharyngeal neoplasms. Genet Epidemiol 2020;44:924-33. [PMID: 32710482 DOI: 10.1002/gepi.22343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sasidharan Nair V, Saleh R, Toor SM, Taha RZ, Ahmed AA, Kurer MA, Murshed K, Alajez NM, Abu Nada M, Elkord E. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer. Clin Epigenetics 2020;12:13. [PMID: 31941522 DOI: 10.1186/s13148-020-0808-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
5 Hughes TA, Brady HJ. Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancer. Cancer Letters 2006;233:338-47. [DOI: 10.1016/j.canlet.2005.03.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
6 Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, Keller G, Bork P, Doeberitz Mv, Gebert JF. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene. 2003;22:2226-2235. [PMID: 12700659 DOI: 10.1038/sj.onc.1206421] [Cited by in Crossref: 120] [Cited by in F6Publishing: 106] [Article Influence: 6.7] [Reference Citation Analysis]
7 Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862-876. [PMID: 12198712 DOI: 10.1053/gast.2002.35392] [Cited by in Crossref: 318] [Cited by in F6Publishing: 283] [Article Influence: 16.7] [Reference Citation Analysis]
8 Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 2010;24:72-85. [PMID: 20048001 DOI: 10.1101/gad.1843810] [Cited by in Crossref: 748] [Cited by in F6Publishing: 700] [Article Influence: 68.0] [Reference Citation Analysis]
9 Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan Ş, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, Singh B, Ganly I, Liau L, Cloughesy TC, Mischel PS, Mellinghoff IK, Chan TA. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet 2013;45:253-61. [PMID: 23354438 DOI: 10.1038/ng.2538] [Cited by in Crossref: 203] [Cited by in F6Publishing: 171] [Article Influence: 25.4] [Reference Citation Analysis]
10 Wang L, Cao XX, Chen Q, Zhu TF, Zhu HG, Zheng L. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation. Cancer Sci. 2009;100:1801-1808. [PMID: 19572978 DOI: 10.1111/j.1349-7006.2009.01246.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
11 Kim S, Choi E, Song K, Kim S, Seo E, Jho E, Kee S. Axin localizes to mitotic spindles and centrosomes in mitotic cells. Experimental Cell Research 2009;315:943-54. [DOI: 10.1016/j.yexcr.2009.01.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
12 Wang X, Zheng L, Zeng Z, Zhou G, Chien J, Qian C, Vasmatzis G, Shridhar V, Chen L, Liu W. DIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding protein. Biochemical and Biophysical Research Communications 2006;347:22-30. [DOI: 10.1016/j.bbrc.2006.06.050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
13 Brembeck FH, Rosário M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 2006;16:51-9. [PMID: 16377174 DOI: 10.1016/j.gde.2005.12.007] [Cited by in Crossref: 469] [Cited by in F6Publishing: 438] [Article Influence: 29.3] [Reference Citation Analysis]
14 Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC, Rha SY. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer. 2007;121:2005-2012. [PMID: 17640062 DOI: 10.1002/ijc.22975] [Cited by in Crossref: 157] [Cited by in F6Publishing: 136] [Article Influence: 11.2] [Reference Citation Analysis]
15 Lorca V, Garre P. Current status of the genetic susceptibility in attenuated adenomatous polyposis. World J Gastrointest Oncol. 2019;11:1101-1114. [PMID: 31908716 DOI: 10.4251/wjgo.v11.i12.1101] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Jass JR, Walsh MD, Barker M, Simms LA, Young J, Leggett BA. Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer 2002;38:858-66. [PMID: 11978509 DOI: 10.1016/s0959-8049(02)00041-2] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
17 Yamaguchi T, Iijima T, Mori T, Takahashi K, Matsumoto H, Miyamoto H, Hishima T, Miyaki M. Accumulation Profile of Frameshift Mutations During Development and Progression of Colorectal Cancer From Patients With Hereditary Nonpolyposis Colorectal Cancer. Diseases of the Colon & Rectum 2006;49:399-406. [DOI: 10.1007/s10350-005-0293-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
18 Doglioni C, Piccinin S, Demontis S, Cangi MG, Pecciarini L, Chiarelli C, Armellin M, Vukosavljevic T, Boiocchi M, Maestro R. Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation. Am J Pathol 2003;163:2277-87. [PMID: 14633602 DOI: 10.1016/s0002-9440(10)63585-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
19 Stamos JL, Weis WI. The β-catenin destruction complex. Cold Spring Harb Perspect Biol. 2013;5:a007898. [PMID: 23169527 DOI: 10.1101/cshperspect.a007898] [Cited by in Crossref: 544] [Cited by in F6Publishing: 475] [Article Influence: 68.0] [Reference Citation Analysis]
20 Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, Nieman MT, Fearon ER, Cho KR. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am J Pathol. 2002;160:1229-1238. [PMID: 11943708 DOI: 10.1016/s0002-9440(10)62550-3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
21 Wu X, Luo F, Li J, Zhong X, Liu K. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. Int J Oncol 2016;48:1333-40. [PMID: 26820603 DOI: 10.3892/ijo.2016.3360] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 9.6] [Reference Citation Analysis]
22 Nguyen HT, Duong HQ. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (review). Oncol Lett. 2018;16:9-18. [PMID: 29928381 DOI: 10.3892/ol.2018.8679] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
23 Fujise T, Iwakiri R, Kakimoto T, Shiraishi R, Sakata Y, Wu B, Tsunada S, Ootani A, Fujimoto K. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1150-G1156. [PMID: 17194898 DOI: 10.1152/ajpgi.00269.2006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
24 Song L, Li Y, He B, Gong Y. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer. Clin Colorectal Cancer. 2015;14:133-145. [PMID: 25799881 DOI: 10.1016/j.clcc.2015.02.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
25 Hughes TA, Brady HJ. Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA. J Biol Chem 2005;280:8581-8. [PMID: 15611123 DOI: 10.1074/jbc.M410806200] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
26 Goldsberry WN, Meza-Perez S, Londoño AI, Katre AA, Mott BT, Roane BM, Goel N, Wall JA, Cooper SJ, Norian LA, Randall TD, Birrer MJ, Arend RC. Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment. Cancers (Basel) 2020;12:E766. [PMID: 32213921 DOI: 10.3390/cancers12030766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
27 Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172-1183. [PMID: 11809808 DOI: 10.1128/mcb.22.4.1172-1183.2002] [Cited by in Crossref: 1165] [Cited by in F6Publishing: 748] [Article Influence: 61.3] [Reference Citation Analysis]
28 Otsuka K, Suzuki T, Shibata H, Kato S, Sakayori M, Shimodaira H, Kanamaru R, Ishioka C. Analysis of the human APC mutation spectrum in a saccharomyces cerevisiae strain with a mismatch repair defect. Int J Cancer 2003;103:624-30. [PMID: 12494469 DOI: 10.1002/ijc.10883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
29 Tice DA, Soloviev I, Polakis P. Activation of the Wnt pathway interferes with serum response element-driven transcription of immediate early genes. J Biol Chem 2002;277:6118-23. [PMID: 11751871 DOI: 10.1074/jbc.M111255200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
30 Im M, Kim DH, Park JS, Chung H, Lee Y, Kim CD, Seo YJ, Lee JH. Alteration of the β-catenin pathway in spiradenoma. J Cutan Pathol 2011;38:657-62. [PMID: 21518380 DOI: 10.1111/j.1600-0560.2011.01706.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Tanabe S, Aoyagi K, Yokozaki H, Sasaki H. Regulation of CTNNB1 signaling in gastric cancer and stem cells. World J Gastrointest Oncol 2016;8:592-8. [PMID: 27574551 DOI: 10.4251/wjgo.v8.i8.592] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
32 Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget 2018;9:5492-508. [PMID: 29435196 DOI: 10.18632/oncotarget.23695] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 16.5] [Reference Citation Analysis]
33 Castiglia D, Bernardini S, Alvino E, Pagani E, De Luca N, Falcinelli S, Pacchiarotti A, Bonmassar E, Zambruno G, D'Atri S. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma. Genes Chromosomes Cancer 2008;47:614-24. [PMID: 18384130 DOI: 10.1002/gcc.20567] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
34 Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, Schweinitz DV, Pietsch T. Mutations and elevated transcriptional activity ofconductin (AXIN2) in hepatoblastomas. J Pathol 2004;204:546-54. [DOI: 10.1002/path.1662] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
35 Doucas H, Garcea G, Neal CP, Manson MM, Berry DP. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 2005;41:365-79. [PMID: 15691635 DOI: 10.1016/j.ejca.2004.11.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
36 Yang Z, Zhao T, Liu H, Zhang L. Ginsenoside Rh2 inhibits hepatocellular carcinoma through beta-catenin and autophagy. Sci Rep. 2016;6:19383. [PMID: 26783250 DOI: 10.1038/srep19383] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
37 Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004;36:417-422. [PMID: 15034581 DOI: 10.1038/ng1330] [Cited by in Crossref: 768] [Cited by in F6Publishing: 681] [Article Influence: 45.2] [Reference Citation Analysis]
38 Angius A, Scanu AM, Arru C, Muroni MR, Rallo V, Deiana G, Ninniri MC, Carru C, Porcu A, Pira G, Uva P, Cossu-Rocca P, De Miglio MR. Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome. Int J Mol Sci 2021;22:1603. [PMID: 33562604 DOI: 10.3390/ijms22041603] [Reference Citation Analysis]
39 Le Floch N, Rivat C, De Wever O, Bruyneel E, Mareel M, Dale T, Gespach C. The proinvasive activity of Wnt‐2 is mediated through a noncanonical Wnt pathway coupled to GSK‐3β and c‐ Jun/AP‐1 signaling. FASEB j 2004;19:144-6. [DOI: 10.1096/fj.04-2373fje] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
40 Scheel SK, Porzner M, Pfeiffer S, Ormanns S, Kirchner T, Jung A. Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. BMC Cancer 2010;10:413. [PMID: 20696052 DOI: 10.1186/1471-2407-10-413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Flanagan DJ, Austin CR, Vincan E, Phesse TJ. Wnt Signalling in Gastrointestinal Epithelial Stem Cells. Genes (Basel). 2018;9. [PMID: 29570681 DOI: 10.3390/genes9040178] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
42 Provost E, Yamamoto Y, Lizardi I, Stern J, D'Aquila TG, Gaynor RB, Rimm DL. Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites. J Biol Chem. 2003;278:31781-31789. [PMID: 12799363 DOI: 10.1074/jbc.M304953200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
43 Strubberg AM, Madison BB. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech. 2017;10:197-214. [PMID: 28250048 DOI: 10.1242/dmm.027441] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 14.3] [Reference Citation Analysis]
44 Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int J Mol Sci 2017;18:E308. [PMID: 28146134 DOI: 10.3390/ijms18020308] [Cited by in Crossref: 193] [Cited by in F6Publishing: 148] [Article Influence: 48.3] [Reference Citation Analysis]
45 Yilmaz E, Mihci E, Guzel Nur B, Alper OM. A novel AXIN2 gene mutation in sagittal synostosis. Am J Med Genet 2018;176:1976-80. [DOI: 10.1002/ajmg.a.40373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
46 Chen F, Zhang F, Tan Z, Hambly BD, Bao S, Tao K. Interleukin-38 in colorectal cancer: a potential role in precision medicine. Cancer Immunol Immunother 2020;69:69-79. [PMID: 31786620 DOI: 10.1007/s00262-019-02440-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
47 Nusse R, Clevers H. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell 2017;169:985-99. [PMID: 28575679 DOI: 10.1016/j.cell.2017.05.016] [Cited by in Crossref: 1477] [Cited by in F6Publishing: 1255] [Article Influence: 369.3] [Reference Citation Analysis]
48 Chen X, Yang J, Evans PM, Liu C. Wnt signaling: the good and the bad. Acta Biochim Biophys Sin (Shanghai) 2008;40:577-94. [PMID: 18604449 DOI: 10.1111/j.1745-7270.2008.00440.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
49 Dionigi G, Bianchi V, Villa F, Rovera F, Boni L, Annoni M, Castano P, Dionigi R. Differences between familial and sporadic forms of colorectal cancer with DNA microsatellite instability. Surg Oncol 2007;16 Suppl 1:S37-42. [PMID: 18023569 DOI: 10.1016/j.suronc.2007.10.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
50 Akiyoshi T, Nakamura M, Koga K, Nakashima H, Yao T, Tsuneyoshi M, Tanaka M, Katano M. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut. 2006;55:991-999. [PMID: 16299030 DOI: 10.1136/gut.2005.080333] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
51 Guo J, Zheng L, Liu W, Wang X, Wang Z, Wang Z, French AJ, Kang D, Chen L, Thibodeau SN, Liu W. Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. Cancer Res 2011;71:2978-87. [PMID: 21467167 DOI: 10.1158/0008-5472.CAN-10-3482] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
52 Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GA. Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling. Mol Oncol. 2018;12:1856-1870. [PMID: 30221473 DOI: 10.1002/1878-0261.12384] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
53 van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res 2001;264:126-34. [PMID: 11237529 DOI: 10.1006/excr.2000.5142] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 4.4] [Reference Citation Analysis]
54 Oving IM, Clevers HC. Molecular causes of colon cancer. Eur J Clin Invest. 2002;32:448-457. [PMID: 12059991 DOI: 10.1046/j.1365-2362.2002.01004.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 5.1] [Reference Citation Analysis]
55 Wang Z, Li Z, Ji H. Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives. Med Res Rev 2021;41:2109-29. [PMID: 33475177 DOI: 10.1002/med.21787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
56 Marvin ML, Mazzoni SM, Herron CM, Edwards S, Gruber SB, Petty EM. AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am J Med Genet A. 2011;155A:898-902. [PMID: 21416598 DOI: 10.1002/ajmg.a.33927] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
57 Chen F, Qu M, Zhang F, Tan Z, Xia Q, Hambly BD, Bao S, Tao K. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer? BMC Cancer 2020;20:92. [PMID: 32013927 DOI: 10.1186/s12885-020-6587-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
58 Sato M, Yamamoto H, Hatanaka Y, Nishijima T, Jiromaru R, Yasumatsu R, Taguchi K, Masuda M, Nakagawa T, Oda Y. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Pathol Res Pract 2018;214:586-92. [PMID: 29496310 DOI: 10.1016/j.prp.2017.12.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
59 Condello S, Cao L, Matei D. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism. FASEB J 2013;27:3100-12. [PMID: 23640056 DOI: 10.1096/fj.12-222620] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
60 Moreno-bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, García-rostán G, Prat J, Guo M, Herman JG, Matías-guiu X, Esteller M, Palacios J. Abnormalities of the APC/β-catenin pathway in endometrial cancer. Oncogene 2002;21:7981-90. [DOI: 10.1038/sj.onc.1205924] [Cited by in Crossref: 179] [Cited by in F6Publishing: 158] [Article Influence: 9.4] [Reference Citation Analysis]
61 Mahmoudi T, Boj SF, Hatzis P, Li VS, Taouatas N, Vries RG, Teunissen H, Begthel H, Korving J, Mohammed S, Heck AJ, Clevers H. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis. PLoS Biol 2010;8:e1000539. [PMID: 21103407 DOI: 10.1371/journal.pbio.1000539] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
62 Yuan H, Xi R, Chen C, Deng M. Differential network analysis via lasso penalized D-trace loss. Biometrika 2017;104:755-70. [DOI: 10.1093/biomet/asx049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
63 Chen H, Fang Y, Zhu H, Li S, Wang T, Gu P, Fang X, Wu Y, Liang J, Zeng Y, Zhang L, Qiu W, Zhang L, Yi X. Protein-protein interaction analysis of distinct molecular pathways in two subtypes of colorectal carcinoma. Mol Med Rep 2014;10:2868-74. [PMID: 25242495 DOI: 10.3892/mmr.2014.2585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Yao H, Ashihara E, Maekawa T. Targeting the Wnt/β-catenin signaling pathway in human cancers. Expert Opin Ther Targets. 2011;15:873-887. [PMID: 21486121 DOI: 10.1517/14728222.2011.577418] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 11.5] [Reference Citation Analysis]
65 Kang HE, Seo Y, Yun JS, Song SH, Han D, Cho ES, Cho SB, Jeon Y, Lee H, Kim HS, Kang J, Yook JI, Kim NH, Kim TI. Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer. Cancers (Basel) 2021;13:3437. [PMID: 34298652 DOI: 10.3390/cancers13143437] [Reference Citation Analysis]
66 Liu X, Rong Z, Shou C. Mycoplasma hyorhinis infection promotes gastric cancer cell motility via β-catenin signaling. Cancer Med 2019;8:5301-12. [PMID: 31321908 DOI: 10.1002/cam4.2357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Fodde R. The APC gene in colorectal cancer. Eur J Cancer. 2002;38:867-871. [PMID: 11978510 DOI: 10.1016/s0959-8049(02)00040-0] [Cited by in Crossref: 229] [Cited by in F6Publishing: 96] [Article Influence: 12.1] [Reference Citation Analysis]
68 Simcha I, Kirkpatrick C, Sadot E, Shtutman M, Polevoy G, Geiger B, Peifer M, Ben-Ze'ev A. Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells. Mol Biol Cell 2001;12:1177-88. [PMID: 11294915 DOI: 10.1091/mbc.12.4.1177] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
69 Sekine S, Shibata T, Sakamoto M, Hirohashi S. Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Oncogene 2002;21:5906-11. [PMID: 12185590 DOI: 10.1038/sj.onc.1205756] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
70 Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W, Okamoto M, Matsumura M, Kawabe T, Shiratori Y. Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res. 2002;93:1213-1220. [PMID: 12460462 DOI: 10.1111/j.1349-7006.2002.tb01226.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
71 Pradhan MP, Prasad NK, Palakal MJ. A systems biology approach to the global analysis of transcription factors in colorectal cancer. BMC Cancer 2012;12:331. [PMID: 22852817 DOI: 10.1186/1471-2407-12-331] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
72 Majid S, Saini S, Dahiya R. Wnt signaling pathways in urological cancers: past decades and still growing. Mol Cancer 2012;11:7. [PMID: 22325146 DOI: 10.1186/1476-4598-11-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
73 Li M, Wang H, Huang T, Wang J, Ding Y, Li Z, Zhang J, Li L. TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling. J Biol Chem 2010;285:13397-404. [PMID: 20194509 DOI: 10.1074/jbc.M109.083246] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
74 Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159:2107-2116. [PMID: 11733361 DOI: 10.1016/s0002-9440(10)63062-3] [Cited by in Crossref: 253] [Cited by in F6Publishing: 101] [Article Influence: 12.7] [Reference Citation Analysis]
75 Tabatabai R, Linhares Y, Bolos D, Mita M, Mita A. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics. Targ Oncol 2017;12:623-41. [DOI: 10.1007/s11523-017-0507-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
76 Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26:570-579. [PMID: 24308963 DOI: 10.1016/j.cellsig.2013.11.032] [Cited by in Crossref: 229] [Cited by in F6Publishing: 209] [Article Influence: 28.6] [Reference Citation Analysis]
77 Pinarbasi E, Gunes EG, Pinarbasi H, Donmez G, Silig Y. AXIN2 polymorphism and its association with prostate cancer in a Turkish population. Med Oncol 2011;28:1373-8. [PMID: 21069480 DOI: 10.1007/s12032-010-9588-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
78 Gespach C. Guidance for life, cell death, and colorectal neoplasia by netrin dependence receptors. Adv Cancer Res 2012;114:87-186. [PMID: 22588057 DOI: 10.1016/B978-0-12-386503-8.00004-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Kurakula K, Koenis DS, van Tiel CM, de Vries CJ. NR4A nuclear receptors are orphans but not lonesome. Biochim Biophys Acta 2014;1843:2543-55. [PMID: 24975497 DOI: 10.1016/j.bbamcr.2014.06.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
80 Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER. Activation of AXIN2 Expression by β-Catenin-T Cell Factor. Journal of Biological Chemistry 2002;277:21657-65. [DOI: 10.1074/jbc.m200139200] [Cited by in Crossref: 254] [Cited by in F6Publishing: 153] [Article Influence: 13.4] [Reference Citation Analysis]
81 Curtin JC, Lorenzi MV. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 2010;1:563-77. [PMID: 21317452 DOI: 10.18632/oncotarget.191] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 11.2] [Reference Citation Analysis]
82 Verkaar F, van Rosmalen JW, Blomenröhr M, van Koppen CJ, Blankesteijn WM, Smits JF, Zaman GJ. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors. Biotechnol Annu Rev 2008;14:253-74. [PMID: 18606367 DOI: 10.1016/S1387-2656(08)00010-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
83 Koch A, Hrychyk A, Hartmann W, Waha A, Mikeska T, Waha A, Schüller U, Sörensen N, Berthold F, Goodyer CG, Wiestler OD, Birchmeier W, Behrens J, Pietsch T. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. Int J Cancer 2007;121:284-91. [PMID: 17373666 DOI: 10.1002/ijc.22675] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
84 Song W, Ma J, Lei B, Yuan X, Cheng B, Yang H, Wang M, Feng Z, Wang L. Sine oculis homeobox 1 promotes proliferation and migration of human colorectal cancer cells through activation of Wnt/β-catenin signaling. Cancer Sci 2019;110:608-16. [PMID: 30548112 DOI: 10.1111/cas.13905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
85 Wemmert S, Willnecker V, Kulas P, Weber S, Lerner C, Berndt S, Wendler O, Schick B. Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas. Tumour Biol 2016;37:5539-49. [PMID: 26572152 DOI: 10.1007/s13277-015-4422-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
86 Jorissen RN, Christie M, Mouradov D, Sakthianandeswaren A, Li S, Love C, Xu ZZ, Molloy PL, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Burgess AW, Busam D, Zhao Q, Strausberg RL, Lipton L, Desai J, Gibbs P, Sieber OM. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer. Br J Cancer. 2015;113:979-988. [PMID: 26305864 DOI: 10.1038/bjc.2015.296] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
87 Norkowski E, Masliah-Planchon J, Le Guellec S, Trassard M, Courrèges JB, Charron-Barra C, Terrier P, Bonvalot S, Coindre JM, Laé M. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors. Am J Surg Pathol 2020;44:1266-73. [PMID: 32590455 DOI: 10.1097/PAS.0000000000001517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
88 Wang Z, Liu CH, Huang S, Chen J. Wnt Signaling in vascular eye diseases. Prog Retin Eye Res 2019;70:110-33. [PMID: 30513356 DOI: 10.1016/j.preteyeres.2018.11.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
89 Ochiai M, Ushigome M, Fujiwara K, Ubagai T, Kawamori T, Sugimura T, Nagao M, Nakagama H. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Am J Pathol 2003;163:1607-14. [PMID: 14507667 DOI: 10.1016/S0002-9440(10)63517-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
90 Borggrefe T, Lauth M, Zwijsen A, Huylebroeck D, Oswald F, Giaimo BD. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways. Biochim Biophys Acta 2016;1863:303-13. [PMID: 26592459 DOI: 10.1016/j.bbamcr.2015.11.020] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 17.2] [Reference Citation Analysis]
91 Thorstensen L, Lind GE, Løvig T, Diep CB, Meling GI, Rognum TO, Lothe RA. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia. 2005;7:99-108. [PMID: 15802015 DOI: 10.1593/neo.04448] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
92 Wu Z, Sun Y, Tang S, Liu C, Zhu S, Wei L, Xu H. AXIN2 rs2240308 polymorphism contributes to increased cancer risk: evidence based on a meta-analysis. Cancer Cell Int 2015;15:68. [PMID: 26161041 DOI: 10.1186/s12935-015-0219-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
93 Labalette C, Nouët Y, Levillayer F, Colnot S, Chen J, Claude V, Huerre M, Perret C, Buendia MA, Wei Y. Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice. PLoS One 2010;5:e10371. [PMID: 20442768 DOI: 10.1371/journal.pone.0010371] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
94 Pan KF, Liu WG, Zhang L, You WC, Lu YY. Mutations in components of the Wnt signaling pathway in gastric cancer. World J Gastroenterol. 2008;14:1570-1574. [PMID: 18330950 DOI: 10.3748/wjg.14.1570] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
95 Mazzoni SM, Fearon ER. AXIN1 and AXIN2 variants in gastrointestinal cancers. Cancer Lett. 2014;355:1-8. [PMID: 25236910 DOI: 10.1016/j.canlet.2014.09.018] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 9.4] [Reference Citation Analysis]
96 Roos J, Grösch S, Werz O, Schröder P, Ziegler S, Fulda S, Paulus P, Urbschat A, Kühn B, Maucher I, Fettel J, Vorup-jensen T, Piesche M, Matrone C, Steinhilber D, Parnham MJ, Maier TJ. Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells? Pharmacology & Therapeutics 2016;157:43-64. [DOI: 10.1016/j.pharmthera.2015.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
97 Stancikova J, Krausova M, Kolar M, Fafilek B, Svec J, Sedlacek R, Neroldova M, Dobes J, Horazna M, Janeckova L, Vojtechova M, Oliverius M, Jirsa M, Korinek V. NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling. Cell Signal 2015;27:245-56. [PMID: 25446263 DOI: 10.1016/j.cellsig.2014.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
98 Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, Rider DN, Vachon CM, Cerhan JR, Olson JE, Couch FJ. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2101-8. [PMID: 18708403 DOI: 10.1158/1055-9965.EPI-08-0134] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
99 Tang W, Dodge M, Gundapaneni D, Michnoff C, Roth M, Lum L. A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci U S A 2008;105:9697-702. [PMID: 18621708 DOI: 10.1073/pnas.0804709105] [Cited by in Crossref: 123] [Cited by in F6Publishing: 107] [Article Influence: 9.5] [Reference Citation Analysis]
100 Duval A, Hamelin R. Genetic instability in human mismatch repair deficient cancers. Ann Genet. 1995;45:71-75. [PMID: 12119215 DOI: 10.1016/s0003-3995(02)01115-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
101 Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003;21:1174-1179. [PMID: 12637487 DOI: 10.1200/jco.2003.04.060] [Cited by in Crossref: 471] [Cited by in F6Publishing: 213] [Article Influence: 26.2] [Reference Citation Analysis]
102 Schepers A, Clevers H. Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb Perspect Biol. 2012;4:a007989. [PMID: 22474007 DOI: 10.1101/cshperspect.a007989] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
103 Rogers HA, Miller S, Lowe J, Brundler MA, Coyle B, Grundy RG. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). Br J Cancer 2009;100:1292-302. [PMID: 19293793 DOI: 10.1038/sj.bjc.6604979] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
104 Putnová B, Putnová I, Škorič M, Buchtová M. The Expression of Selected Wnt Pathway Members (FZD6, AXIN2 and β-Catenin) in Canine Oral Squamous Cell Carcinoma and Acanthomatous Ameloblastoma. Animals (Basel) 2021;11:1615. [PMID: 34072517 DOI: 10.3390/ani11061615] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Aoki M, Sobek V, Maslyar DJ, Hecht A, Vogt PK. Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes. Oncogene 2002;21:6983-91. [PMID: 12370820 DOI: 10.1038/sj.onc.1205796] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
106 Fang Z, Deng J, Zhang L, Xiang X, Yu F, Chen J, Feng M, Xiong J. TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway. Oncol Lett 2017;13:1797-806. [PMID: 28454326 DOI: 10.3892/ol.2017.5604] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
107 Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 2007;56:417-25. [PMID: 16840506 DOI: 10.1136/gut.2006.093310] [Cited by in Crossref: 190] [Cited by in F6Publishing: 159] [Article Influence: 12.7] [Reference Citation Analysis]
108 Jacobsen A, Heijmans N, Verkaar F, Smit MJ, Heringa J, van Amerongen R, Feenstra KA. Construction and Experimental Validation of a Petri Net Model of Wnt/β-Catenin Signaling. PLoS One 2016;11:e0155743. [PMID: 27218469 DOI: 10.1371/journal.pone.0155743] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
109 Anwar M, Kochhar R, Singh R, Bhatia A, Vaiphei K, Mahmood A, Mahmood S. Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis. Mol Carcinog 2016;55:1627-38. [PMID: 26373808 DOI: 10.1002/mc.22414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Ma C, Liu C, Huang P, Kaku H, Chen J, Guo K, Ueki H, Sakai A, Nasu Y, Kumon H, Shimizu K, Watanabe M. Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer. Oncol Lett 2014;8:789-94. [PMID: 25013500 DOI: 10.3892/ol.2014.2177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
111 Wang Z, Zhang M, Luo W, Zhang Y, Ji H. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction. J Med Chem 2021;64:5886-904. [PMID: 33902288 DOI: 10.1021/acs.jmedchem.1c00046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Dahlmann M, Kobelt D, Walther W, Mudduluru G, Stein U. S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction. Cancers (Basel) 2016;8:E59. [PMID: 27331819 DOI: 10.3390/cancers8060059] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
113 Schuijers J, Clevers H. Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J. 2012;31:2685-2696. [PMID: 22617424 DOI: 10.1038/emboj.2012.149] [Cited by in Crossref: 160] [Cited by in F6Publishing: 134] [Article Influence: 17.8] [Reference Citation Analysis]
114 Li Z, Wang Y, Li Y, Yin W, Mo L, Qian X, Zhang Y, Wang G, Bu F, Zhang Z, Ren X, Zhu B, Niu C, Xiao W, Zhang W. Ube2s stabilizes β-Catenin through K11-linked polyubiquitination to promote mesendoderm specification and colorectal cancer development. Cell Death Dis 2018;9:456. [PMID: 29674637 DOI: 10.1038/s41419-018-0451-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
115 Bugter JM, Fenderico N, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer 2021;21:5-21. [PMID: 33097916 DOI: 10.1038/s41568-020-00307-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 27.0] [Reference Citation Analysis]
116 Ardila HJ, Sanabria-Salas MC, Meneses X, Rios R, Huertas-Salgado A, Serrano ML. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas. Mol Clin Oncol 2019;11:201-7. [PMID: 31316774 DOI: 10.3892/mco.2019.1876] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
117 Merker SR, Weitz J, Stange DE. Gastrointestinal organoids: How they gut it out. Dev Biol. 2016;420:239-250. [PMID: 27521455 DOI: 10.1016/j.ydbio.2016.08.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
118 Koizumi K, Alonso S, Miyaki Y, Okada S, Ogura H, Shiiya N, Konishi F, Taya T, Perucho M, Suzuki K. Array-based identification of common DNA methylation alterations in ulcerative colitis. Int J Oncol 2012;40:983-94. [PMID: 22159500 DOI: 10.3892/ijo.2011.1283] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
119 Sato K, Okazaki Y, Tonogi M, Tanaka Y, Yamane GY. Expression of beta-catenin in rat oral epithelial dysplasia induced by 4-nitroquinoline 1-oxide. Oral Oncol. 2002;38:772-778. [PMID: 12570056 DOI: 10.1016/s1368-8375(02)00044-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
120 Knippschild U, Krüger M, Richter J, Xu P, García-Reyes B, Peifer C, Halekotte J, Bakulev V, Bischof J. The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis. Front Oncol 2014;4:96. [PMID: 24904820 DOI: 10.3389/fonc.2014.00096] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 18.1] [Reference Citation Analysis]
121 Oh S, Lee E, Lee J, Lim Y, Kim J, Woo S. Comparison of the effects of 40% oxygen and two atmospheric absolute air pressure conditions on stress-induced premature senescence of normal human diploid fibroblasts. Cell Stress Chaperones 2008;13:447-58. [PMID: 18465208 DOI: 10.1007/s12192-008-0041-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
122 Montgomery E, Lee J, Abraham SC, Wu T. Superficial Fibromatoses are Genetically Distinct from Deep Fibromatoses. Mod Pathol 2001;14:695-701. [DOI: 10.1038/modpathol.3880374] [Cited by in Crossref: 88] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
123 Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006;25:7531-7. [DOI: 10.1038/sj.onc.1210059] [Cited by in Crossref: 393] [Cited by in F6Publishing: 365] [Article Influence: 26.2] [Reference Citation Analysis]
124 Guimier A, Ragazzon B, Assié G, Tissier F, Dousset B, Bertherat J, Gaujoux S. AXIN genetic analysis in adrenocortical carcinomas updated. J Endocrinol Invest 2013;36:1000-3. [PMID: 23812285 DOI: 10.3275/9022] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
125 Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol. 2008;4:647-660. [PMID: 18922122 DOI: 10.2217/14796694.4.5.647] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
126 Parveen N, Hussain MU, Pandith AA, Mudassar S. Diversity of axin in signaling pathways and its relation to colorectal cancer. Med Oncol 2011;28:259-67. [DOI: 10.1007/s12032-010-9722-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
127 Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469-480. [PMID: 17081971 DOI: 10.1016/j.cell.2006.10.018] [Cited by in Crossref: 3754] [Cited by in F6Publishing: 3537] [Article Influence: 250.3] [Reference Citation Analysis]
128 Yue H, Liang J, Yang K, Hua B, Bian Z. Functional analysis of a novel missense mutation in AXIN2 associated with non-syndromic tooth agenesis. Eur J Oral Sci 2016;124:228-33. [PMID: 27090353 DOI: 10.1111/eos.12273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
129 MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 2009;17:9-26. [PMID: 19619488 DOI: 10.1016/j.devcel.2009.06.016] [Cited by in Crossref: 3353] [Cited by in F6Publishing: 3087] [Article Influence: 279.4] [Reference Citation Analysis]
130 Yun SI, Kim HH, Yoon JH, Park WS, Hahn MJ, Kim HC, Chung CH, Kim KK. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer. Mol Oncol 2015;9:1834-51. [PMID: 26189775 DOI: 10.1016/j.molonc.2015.06.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 10.3] [Reference Citation Analysis]
131 Chang SC, Lan YT, Lin PC, Yang SH, Lin CH, Liang WY, Chen WS, Jiang JK, Lin JK. Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences. Cancer Med 2020;9:476-86. [PMID: 31769227 DOI: 10.1002/cam4.2702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;21:4863-4871. [PMID: 12101426 DOI: 10.1038/sj.onc.1205591] [Cited by in Crossref: 332] [Cited by in F6Publishing: 293] [Article Influence: 17.5] [Reference Citation Analysis]
133 Oefner PJ, Huber CG. A decade of high-resolution liquid chromatography of nucleic acids on styrene–divinylbenzene copolymers. Journal of Chromatography B 2002;782:27-55. [DOI: 10.1016/s1570-0232(02)00700-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
134 Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Surendra A, Kumar S, Green B, Geddes K, Pezo RC, Navarre WW, Milosevic M, Wilson BC, Girardin SE, Wolever TMS, Edelmann W, Guttman DS, Philpott DJ, Martin A. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014;158:288-299. [PMID: 25036629 DOI: 10.1016/j.cell.2014.04.051] [Cited by in Crossref: 234] [Cited by in F6Publishing: 211] [Article Influence: 33.4] [Reference Citation Analysis]
135 Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, Cheyette BN, Yu Q. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 2008;13:529-41. [PMID: 18538736 DOI: 10.1016/j.ccr.2008.04.019] [Cited by in Crossref: 158] [Cited by in F6Publishing: 143] [Article Influence: 12.2] [Reference Citation Analysis]
136 Alanazi MS, Parine NR, Shaik JP, Alabdulkarim HA, Ajaj SA, Khan Z. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients. PLoS One. 2013;8:e59555. [PMID: 23516639 DOI: 10.1371/journal.pone.0059555] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
137 Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149:1192-1205. [PMID: 22682243 DOI: 10.1016/j.cell.2012.05.012] [Cited by in Crossref: 3294] [Cited by in F6Publishing: 2994] [Article Influence: 366.0] [Reference Citation Analysis]
138 Albuquerque C, Baltazar C, Filipe B, Penha F, Pereira T, Smits R, Cravo M, Lage P, Fidalgo P, Claro I, Rodrigues P, Veiga I, Ramos JS, Fonseca I, Leitão CN, Fodde R. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer 2010;49:746-59. [PMID: 20544848 DOI: 10.1002/gcc.20786] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
139 Dai F, Zhu LJ, Zhang W, Mi YY, Sun HY, Zhang LF, Yue C, Wu XY, Zuo L, Bai Y. The association between three AXIN2 variants and cancer risk. J Cell Biochem 2019;120:15561-71. [PMID: 31038806 DOI: 10.1002/jcb.28823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Yu J, Virshup DM. Updating the Wnt pathways. Biosci Rep 2014;34:e00142. [PMID: 25208913 DOI: 10.1042/BSR20140119] [Cited by in Crossref: 55] [Cited by in F6Publishing: 19] [Article Influence: 7.9] [Reference Citation Analysis]
141 Furukawa T, Konishi F, Shitoh K, Kojima M, Nagai H, Tsukamoto T. Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma. Cancer 2002;94:911-20. [DOI: 10.1002/cncr.10332] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
142 van Es JH, Clevers H. Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med. 2005;11:496-502. [PMID: 16214417 DOI: 10.1016/j.molmed.2005.09.008] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 6.8] [Reference Citation Analysis]
143 Lamba A, Parekh P, Dvorak CC, Karlitz J. Pedigree analysis supports a correlation between an AXIN2 variant and polyposis/colorectal cancer. WJMG 2018;8:1-4. [DOI: 10.5496/wjmg.v8.i1.1] [Reference Citation Analysis]
144 Bastakoty D, Young PP. Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration. FASEB J 2016;30:3271-84. [PMID: 27335371 DOI: 10.1096/fj.201600502R] [Cited by in Crossref: 59] [Cited by in F6Publishing: 31] [Article Influence: 11.8] [Reference Citation Analysis]
145 Li S, Wang C, Liu X, Hua S, Liu X. The roles of AXIN2 in tumorigenesis and epigenetic regulation. Fam Cancer 2015;14:325-31. [PMID: 25504512 DOI: 10.1007/s10689-014-9775-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
146 Catalano V, Eleuteri C, Campoccia G, Giacobini G, Zane M, Stassi G, Parmiani G, Maccalli C. Resistance of Cancer Stem Cells to Cell-Mediated Immune Responses. In: Bonavida B, Chouaib S, editors. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Cham: Springer International Publishing; 2015. pp. 3-29. [DOI: 10.1007/978-3-319-17807-3_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Muller T, Bain G, Wang X, Papkoff J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res. 2002;280:119-133. [PMID: 12372345 DOI: 10.1006/excr.2002.5630] [Cited by in Crossref: 130] [Cited by in F6Publishing: 115] [Article Influence: 6.8] [Reference Citation Analysis]
148 Pedone E, Marucci L. Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate. Genes (Basel) 2019;10:E176. [PMID: 30823613 DOI: 10.3390/genes10020176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
149 Carinci F, Piattelli A, Guida L, Perrotti V, Laino G, Oliva A, Annunziata M, Palmieri A, Pezzetti F. Effects of Emdogain on osteoblast gene expression. Oral Dis 2006;12:329-42. [PMID: 16700745 DOI: 10.1111/j.1601-0825.2005.01204.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
150 Zhong A, Pan X, Shi M, Xu H. -148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis. Onco Targets Ther 2015;8:1957-66. [PMID: 26251618 DOI: 10.2147/OTT.S86738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
151 Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5:997-1014. [PMID: 17139285 DOI: 10.1038/nrd2154] [Cited by in Crossref: 538] [Cited by in F6Publishing: 476] [Article Influence: 38.4] [Reference Citation Analysis]
152 Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003;129:199-221. [DOI: 10.1007/s00432-003-0431-0] [Cited by in Crossref: 338] [Cited by in F6Publishing: 324] [Article Influence: 18.8] [Reference Citation Analysis]
153 Yardy GW, Brewster SF. Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 2005;8:119-26. [PMID: 15809669 DOI: 10.1038/sj.pcan.4500794] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 6.7] [Reference Citation Analysis]
154 Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004;74:1043-1050. [PMID: 15042511 DOI: 10.1086/386293] [Cited by in Crossref: 419] [Cited by in F6Publishing: 346] [Article Influence: 24.6] [Reference Citation Analysis]
155 Buda A, Pignatelli M. Genetics – cellular basis. British Medical Bulletin 2002;64:45-58. [DOI: 10.1093/bmb/64.1.45] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
156 Fujimuro M, Hayward SD. Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers. J Mol Med (Berl). 2004;82:223-231. [PMID: 14991150 DOI: 10.1007/s00109-003-0519-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
157 Naghibalhossaini F, Zamani M, Mokarram P, Khalili I, Rasti M, Mostafavi-Pour Z. Epigenetic and genetic analysis of WNT signaling pathway in sporadic colorectal cancer patients from Iran. Mol Biol Rep. 2012;39:6171-6178. [PMID: 22207181 DOI: 10.1007/s11033-011-1434-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
158 Tan SH, Barker N. Wnt Signaling in Adult Epithelial Stem Cells and Cancer. Prog Mol Biol Transl Sci 2018;153:21-79. [PMID: 29389518 DOI: 10.1016/bs.pmbts.2017.11.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
159 Zhu G, Hu J, Xi R. The cellular niche for intestinal stem cells: a team effort. Cell Regen 2021;10:1. [PMID: 33385259 DOI: 10.1186/s13619-020-00061-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
160 Fujiwara M, Kato S, Niwa Y, Suzuki T, Tsuchiya M, Sasazawa Y, Dohmae N, Simizu S. C -mannosylation of R-spondin3 regulates its secretion and activity of Wnt/β-catenin signaling in cells. FEBS Lett 2016;590:2639-49. [DOI: 10.1002/1873-3468.12274] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
161 Bhattacharyya S, Feferman L, Borthakur S, Tobacman JK. Common food additive carrageenan stimulates Wnt/ β-catenin signaling in colonic epithelium by inhibition of nucleoredoxin reduction. Nutr Cancer 2014;66:117-27. [PMID: 24328990 DOI: 10.1080/01635581.2014.852228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
162 Huang W, Zhang J, Huo M, Gao J, Yang T, Yin X, Wang P, Leng S, Feng D, Chen Y, Yang Y, Wang Y. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway. Adv Sci (Weinh) 2021;8:2001515. [PMID: 34026424 DOI: 10.1002/advs.202001515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 McCubrey JA, Rakus D, Gizak A, Steelman LS, Abrams SL, Lertpiriyapong K, Fitzgerald TL, Yang LV, Montalto G, Cervello M, Libra M, Nicoletti F, Scalisi A, Torino F, Fenga C, Neri LM, Marmiroli S, Cocco L, Martelli AM. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer. Biochim Biophys Acta 2016;1863:2942-76. [PMID: 27612668 DOI: 10.1016/j.bbamcr.2016.09.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 17.0] [Reference Citation Analysis]
164 Salahshor S, Woodgett JR. The links between axin and carcinogenesis. J Clin Pathol. 2005;58:225-236. [PMID: 15735151 DOI: 10.1136/jcp.2003.009506] [Cited by in Crossref: 158] [Cited by in F6Publishing: 151] [Article Influence: 9.9] [Reference Citation Analysis]
165 Lee KE, Ko J, Shin TJ, Hyun HK, Lee SH, Kim JW. Oligodontia and curly hair occur with ectodysplasin-a mutations. J Dent Res 2014;93:371-5. [PMID: 24487376 DOI: 10.1177/0022034514522059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
166 Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M, Asahara T. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 2002;33:73-81. [PMID: 11746989 DOI: 10.1002/gcc.1226] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
167 Figeac N, Zammit PS. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function. Cell Signal 2015;27:1652-65. [PMID: 25866367 DOI: 10.1016/j.cellsig.2015.03.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
168 Chalothorn LA, Beeman CS, Ebersole JL, Kluemper GT, Hicks EP, Kryscio RJ, DeSimone CP, Modesitt SC. Hypodontia as a risk marker for epithelial ovarian cancer: a case-controlled study. J Am Dent Assoc 2008;139:163-9. [PMID: 18245684 DOI: 10.14219/jada.archive.2008.0132] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
169 Yang W, Yee AJ. Versican 3′-untranslated region (3′UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014;1843:1373-85. [DOI: 10.1016/j.bbamcr.2014.02.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
170 Alberici P, Gaspar C, Franken P, Gorski MM, de Vries I, Scott RJ, Ristimäki A, Aaltonen LA, Fodde R. Smad4 haploinsufficiency: a matter of dosage. Pathogenetics 2008;1:2. [PMID: 19014666 DOI: 10.1186/1755-8417-1-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
171 Mohammed MK, Shao C, Wang J, Wei Q, Wang X, Collier Z, Tang S, Liu H, Zhang F, Huang J, Guo D, Lu M, Liu F, Liu J, Ma C, Shi LL, Athiviraham A, He TC, Lee MJ. Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 2016;3:11-40. [PMID: 27077077 DOI: 10.1016/j.gendis.2015.12.004] [Cited by in F6Publishing: 131] [Reference Citation Analysis]
172 Scholer-Dahirel A, Schlabach MR, Loo A, Bagdasarian L, Meyer R, Guo R, Woolfenden S, Yu KK, Markovits J, Killary K. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A. 2011;108:17135-17140. [PMID: 21949247 DOI: 10.1073/pnas.1104182108] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
173 van Es JH, Haegebarth A, Kujala P, Itzkovitz S, Koo BK, Boj SF, Korving J, van den Born M, van Oudenaarden A, Robine S, Clevers H. A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol Cell Biol 2012;32:1918-27. [PMID: 22393260 DOI: 10.1128/MCB.06288-11] [Cited by in Crossref: 165] [Cited by in F6Publishing: 99] [Article Influence: 18.3] [Reference Citation Analysis]
174 McGee-Lawrence ME, Li X, Bledsoe KL, Wu H, Hawse JR, Subramaniam M, Razidlo DF, Stensgard BA, Stein GS, van Wijnen AJ, Lian JB, Hsu W, Westendorf JJ. Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice. J Biol Chem 2013;288:5291-302. [PMID: 23300083 DOI: 10.1074/jbc.M112.414995] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
175 Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387-398. [PMID: 18432252 DOI: 10.1038/nrc2389] [Cited by in Crossref: 1052] [Cited by in F6Publishing: 970] [Article Influence: 80.9] [Reference Citation Analysis]
176 Engler TA, Furness K, Malhotra S, Sanchez-martinez C, Shih C, Xie W, Zhu G, Zhou X, Conner S, Faul MM, Sullivan KA, Kolis SP, Brooks HB, Patel B, Schultz RM, Dehahn TB, Kirmani K, Spencer CD, Watkins SA, Considine EL, Dempsey JA, Ogg CA, Stamm NB, Anderson BD, Campbell RM, Vasudevan V, Lytle ML. Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles. Bioorganic & Medicinal Chemistry Letters 2003;13:2261-7. [DOI: 10.1016/s0960-894x(03)00461-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
177 Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, Zhao YJ, Li XN, Cai WW, El-Naggar AK, Baladandayuthapani V, Kittrell FS, Rao PH, Medina D, Pati D. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A 2008;105:13033-8. [PMID: 18728194 DOI: 10.1073/pnas.0801610105] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 8.3] [Reference Citation Analysis]
178 Ye X, Attaie AB. Genetic Basis of Nonsyndromic and Syndromic Tooth Agenesis. J Pediatr Genet 2016;5:198-208. [PMID: 27895972 DOI: 10.1055/s-0036-1592421] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
179 Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J 2014;33:146-56. [PMID: 24413017 DOI: 10.1002/embj.201385358] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 15.7] [Reference Citation Analysis]
180 Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner DL, Messersmith WA, Lieu CH. Targeting the WNT Signaling Pathway in Cancer Therapeutics. Oncologist 2015;20:1189-98. [PMID: 26306903 DOI: 10.1634/theoncologist.2015-0057] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 11.8] [Reference Citation Analysis]
181 Little DW 3rd, Dumontet T, LaPensee CR, Hammer GD. β-catenin in adrenal zonation and disease. Mol Cell Endocrinol 2021;522:111120. [PMID: 33338548 DOI: 10.1016/j.mce.2020.111120] [Reference Citation Analysis]
182 Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C, Garcia PD, Randazzo FM, Escobedo J, Fantl WJ, Williams LT. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A 2001;98:14973-8. [PMID: 11752446 DOI: 10.1073/pnas.261574498] [Cited by in Crossref: 247] [Cited by in F6Publishing: 237] [Article Influence: 13.0] [Reference Citation Analysis]
183 Dai J, Gao H, Xue J, Lin W, Zheng L. The Association Between AXIN2 Gene Polymorphisms and the Risk of Breast Cancer in Chinese Women. Genet Test Mol Biomarkers 2019;23:393-400. [PMID: 31063404 DOI: 10.1089/gtmb.2018.0309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
184 Clements WM, Lowy AM, Groden J. Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors. Clin Colorectal Cancer 2003;3:113-20. [PMID: 12952568 DOI: 10.3816/ccc.2003.n.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
185 Mokhtar NM, Ramzi NH, Yin-Ling W, Rose IM, Hatta Mohd Dali AZ, Jamal R. Laser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer. Cancer Invest 2012;30:156-64. [PMID: 22122087 DOI: 10.3109/07357907.2011.633290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
186 Nakamura T, Nakamura T, Matsumoto K. The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology. J Cell Mol Med 2008;12:391-408. [PMID: 18088386 DOI: 10.1111/j.1582-4934.2007.00201.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
187 Suriano G, Vrcelj N, Senz J, Ferreira P, Masoudi H, Cox K, Nabais S, Lopes C, Machado JC, Seruca R, Carneiro F, Huntsman DG. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 2005;42:238-46. [PMID: 15609344 DOI: 10.1002/gcc.20135] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
188 Lipkin SM, Wang V, Stoler DL, Anderson GR, Kirsch I, Hadley D, Lynch HT, Collins FS. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Hum Mutat. 2001;17:389-396. [PMID: 11317354 DOI: 10.1002/humu.1114] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
189 Mostowska A, Biedziak B, Trzeciak WH. A novel mutation in PAX9 causes familial form of molar oligodontia. Eur J Hum Genet 2006;14:173-9. [PMID: 16333316 DOI: 10.1038/sj.ejhg.5201536] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
190 Otero L, Lacunza E, Vasquez V, Arbelaez V, Cardier F, González F. Variations in AXIN2 predict risk and prognosis of colorectal cancer. BDJ Open 2019;5:13. [PMID: 31632692 DOI: 10.1038/s41405-019-0022-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
191 Muto Y, Maeda T, Suzuki K, Kato T, Watanabe F, Kamiyama H, Saito M, Koizumi K, Miyaki Y, Konishi F, Alonso S, Perucho M, Rikiyama T. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability. BMC Cancer 2014;14:466. [PMID: 24964857 DOI: 10.1186/1471-2407-14-466] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
192 Adarichev VA, Vaiskunaite R, Niu J, Balyasnikova IV, Voyno-Yasenetskaya TA. G alpha 13-mediated transformation and apoptosis are permissively dependent on basal ERK activity. Am J Physiol Cell Physiol 2003;285:C922-34. [PMID: 12736137 DOI: 10.1152/ajpcell.00115.2003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
193 Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843-850. [PMID: 15829953 DOI: 10.1038/nature03319] [Cited by in Crossref: 2477] [Cited by in F6Publishing: 2278] [Article Influence: 154.8] [Reference Citation Analysis]
194 Sakamoto I, Ohwada S, Toya H, Togo N, Kashiwabara K, Oyama T, Nakajima T, Ito H, Adachi S, Jigami T, Akiyama T. Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma. Cancer Sci 2007;98:83-7. [PMID: 17129358 DOI: 10.1111/j.1349-7006.2006.00363.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
195 Hrckulak D, Janeckova L, Lanikova L, Kriz V, Horazna M, Babosova O, Vojtechova M, Galuskova K, Sloncova E, Korinek V. Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells. Genes (Basel) 2018;9:E439. [PMID: 30200414 DOI: 10.3390/genes9090439] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
196 Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara SI, Miyakura Y, Nagai H, Mano H. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 2006;25:139-46. [PMID: 16247484 DOI: 10.1038/sj.onc.1209009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
197 Atayar C, Kok K, Kluiver J, Bosga A, van den Berg E, van der Vlies P, Blokzijl T, Harms G, Davelaar I, Sikkema-Raddatz B, Martin-Subero JI, Siebert R, Poppema S, van den Berg A. BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. Hum Pathol 2006;37:675-83. [PMID: 16733207 DOI: 10.1016/j.humpath.2006.01.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
198 Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202-1209. [PMID: 16670761 DOI: 10.1172/jci28551] [Cited by in Crossref: 964] [Cited by in F6Publishing: 441] [Article Influence: 64.3] [Reference Citation Analysis]
199 Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology 2010;138:2059-72. [PMID: 20420946 DOI: 10.1053/j.gastro.2009.12.065] [Reference Citation Analysis]
200 Kurihara T, Ikeda S, Ishizaki Y, Fujimori M, Tokumoto N, Hirata Y, Ozaki S, Okajima M, Sugino K, Asahara T. Immunohistochemical and Sequencing Analyses of the Wnt Signaling Components in Japanese Anaplastic Thyroid Cancers. Thyroid 2004;14:1020-9. [DOI: 10.1089/thy.2004.14.1020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
201 Trojan J, Brieger A, Raedle J, Weber N, Kriener S, Kronenberger B, Caspary WF, Zeuzem S. BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability. Int J Colorectal Dis. 2004;19:538-544. [PMID: 15088110 DOI: 10.1007/s00384-004-0597-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
202 Rennoll SA, Konsavage WM Jr, Yochum GS. Nuclear AXIN2 represses MYC gene expression. Biochem Biophys Res Commun 2014;443:217-22. [PMID: 24299953 DOI: 10.1016/j.bbrc.2013.11.089] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
203 Guo J, Cagatay T, Zhou G, Chan CC, Blythe S, Suyama K, Zheng L, Pan K, Qian C, Hamelin R, Thibodeau SN, Klein PS, Wharton KA, Liu W. Mutations in the human naked cuticle homolog NKD1 found in colorectal cancer alter Wnt/Dvl/beta-catenin signaling. PLoS One 2009;4:e7982. [PMID: 19956716 DOI: 10.1371/journal.pone.0007982] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
204 Noffsinger AE, Hart J. Serrated adenoma: a distinct form of non-polypoid colorectal neoplasia? Gastrointest Endosc Clin N Am 2010;20:543-63. [PMID: 20656251 DOI: 10.1016/j.giec.2010.03.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
205 Johnson ML, Rajamannan N. Diseases of Wnt signaling. Rev Endocr Metab Disord. 2006;7:41-49. [PMID: 16944325 DOI: 10.1007/s11154-006-9003-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
206 Yu F, Zhou C, Zeng H, Liu Y, Li S. BMI1 activates WNT signaling in colon cancer by negatively regulating the WNT antagonist IDAX. Biochemical and Biophysical Research Communications 2018;496:468-74. [DOI: 10.1016/j.bbrc.2018.01.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
207 Xichun Z. Long-term exposure to various types of dietary fat modulates acrylamide-induced preneoplastic lesions of colon mucosa through Wnt/ β -catenin signaling in rats. Toxicology Mechanisms and Methods 2009;19:285-91. [DOI: 10.1080/15376510802637670] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
208 Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Leggett B, Whitehall V. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017;66:97-106. [PMID: 26475632 DOI: 10.1136/gutjnl-2015-310456] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 17.3] [Reference Citation Analysis]
209 Najdi R, Holcombe RF, Waterman ML. Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog. 2011;10:5. [PMID: 21483657 DOI: 10.4103/1477-3163.78111] [Cited by in Crossref: 130] [Cited by in F6Publishing: 120] [Article Influence: 13.0] [Reference Citation Analysis]
210 Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113-130. [PMID: 17204026 DOI: 10.1111/j.1365-2559.2006.02549.x] [Cited by in Crossref: 884] [Cited by in F6Publishing: 800] [Article Influence: 63.1] [Reference Citation Analysis]
211 Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer. 2001;1:55-67. [PMID: 11900252 DOI: 10.1038/35094067] [Cited by in Crossref: 603] [Cited by in F6Publishing: 552] [Article Influence: 31.7] [Reference Citation Analysis]
212 Anderson CB, Neufeld KL, White RL. Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci U S A 2002;99:8683-8. [PMID: 12072559 DOI: 10.1073/pnas.122235399] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 4.1] [Reference Citation Analysis]
213 Suraweera N, Robinson J, Volikos E, Guenther T, Talbot I, Tomlinson I, Silver A. Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int J Cancer 2006;119:1837-42. [DOI: 10.1002/ijc.22046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
214 Fancy SP, Harrington EP, Baranzini SE, Silbereis JC, Shiow LR, Yuen TJ, Huang EJ, Lomvardas S, Rowitch DH. Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer. Nat Neurosci 2014;17:506-12. [PMID: 24609463 DOI: 10.1038/nn.3676] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
215 Diede SJ, Guenthoer J, Geng LN, Mahoney SE, Marotta M, Olson JM, Tanaka H, Tapscott SJ. DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. Proc Natl Acad Sci USA. 2010;107:234-239. [PMID: 19966297 DOI: 10.1073/pnas.0907606106] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
216 Fuentes NR, Salinas ML, Kim E, Chapkin RS. Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization. Biochim Biophys Acta Biomembr 2017;1859:1668-78. [PMID: 28342710 DOI: 10.1016/j.bbamem.2017.03.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
217 Sue Ng S, Mahmoudi T, Li VS, Hatzis P, Boersema PJ, Mohammed S, Heck AJ, Clevers H. MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway. Biological Chemistry 2010;391:171-80. [DOI: 10.1515/bc.2010.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
218 Vincan E, Flanagan DJ, Pouliot N, Brabletz T, Spaderna S. Variable FZD7 expression in colorectal cancers indicates regulation by the tumour microenvironment. Dev Dyn 2010;239:311-7. [PMID: 19655379 DOI: 10.1002/dvdy.22045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
219 Singh S, Arcaroli J, Chen Y, Thompson DC, Messersmith W, Jimeno A, Vasiliou V. ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways. PLoS One 2015;10:e0121648. [PMID: 25950950 DOI: 10.1371/journal.pone.0121648] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
220 Dihlmann S, von Knebel Doeberitz M. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer. 2005;113:515-524. [PMID: 15472907 DOI: 10.1002/ijc.20609] [Cited by in Crossref: 142] [Cited by in F6Publishing: 120] [Article Influence: 8.9] [Reference Citation Analysis]
221 Bokhari A, Jonchere V, Lagrange A, Bertrand R, Svrcek M, Marisa L, Buhard O, Greene M, Demidova A, Jia J. Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability. Oncogenesis. 2018;7:70. [PMID: 30228267 DOI: 10.1038/s41389-018-0079-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
222 Bylstra Y, Lim WK, Kam S, Tham KW, Wu RR, Teo JX, Davila S, Kuan JL, Chan SH, Bertin N, Yang CX, Rozen S, Teh BT, Yeo KK, Cook SA, Jamuar SS, Ginsburg GS, Orlando LA, Tan P. Family history assessment significantly enhances delivery of precision medicine in the genomics era. Genome Med 2021;13:3. [PMID: 33413596 DOI: 10.1186/s13073-020-00819-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
223 He J, Ling L, Liu Z, Ren X, Wan L, Tu C, Li Z. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int 2021;21:313. [PMID: 34130697 DOI: 10.1186/s12935-021-02013-8] [Reference Citation Analysis]
224 Clevers H. The Intestinal Crypt, A Prototype Stem Cell Compartment. Cell 2013;154:274-84. [DOI: 10.1016/j.cell.2013.07.004] [Cited by in Crossref: 634] [Cited by in F6Publishing: 548] [Article Influence: 79.3] [Reference Citation Analysis]
225 Ramos-Betancourt N, Field MG, Davila-Alquisiras JH, Karp CL, Hernández-Zimbrón LF, García-Vázquez R, Vazquez-Romo KA, Wang G, Fromow-Guerra J, Hernandez-Quintela E, Galor A. Whole exome profiling and mutational analysis of Ocular Surface Squamous Neoplasia. Ocul Surf 2020;18:627-32. [PMID: 32717381 DOI: 10.1016/j.jtos.2020.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Rajamäki K, Taira A, Katainen R, Välimäki N, Kuosmanen A, Plaketti RM, Seppälä TT, Ahtiainen M, Wirta EV, Vartiainen E, Sulo P, Ravantti J, Lehtipuro S, Granberg KJ, Nykter M, Tanskanen T, Ristimäki A, Koskensalo S, Renkonen-Sinisalo L, Lepistö A, Böhm J, Taipale J, Mecklin JP, Aavikko M, Palin K, Aaltonen LA. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer. Gastroenterology 2021;161:592-607. [PMID: 33930428 DOI: 10.1053/j.gastro.2021.04.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Thorstensen L, Diep CB, Meling GI, Aagesen TH, Ahrens CH, Rognum TO, Lothe RA. WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology. 2001;121:1275-1280. [PMID: 11729105 DOI: 10.1053/gast.2001.29570] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
228 Sheng QS, He KX, Li JJ, Zhong ZF, Wang FX, Pan LL, Lin JJ. Comparison of Gut Microbiome in Human Colorectal Cancer in Paired Tumor and Adjacent Normal Tissues. Onco Targets Ther 2020;13:635-46. [PMID: 32021305 DOI: 10.2147/OTT.S218004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
229 Koppert LB, van der Velden AW, van de Wetering M, Abbou M, van den Ouweland AM, Tilanus HW, Wijnhoven BP, Dinjens WN. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. Br J Cancer 2004;90:892-9. [PMID: 14970870 DOI: 10.1038/sj.bjc.6601589] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
230 Kourtidis A, Lu R, Pence LJ, Anastasiadis PZ. A central role for cadherin signaling in cancer. Exp Cell Res 2017;358:78-85. [PMID: 28412244 DOI: 10.1016/j.yexcr.2017.04.006] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 26.0] [Reference Citation Analysis]
231 Kalkat M, De Melo J, Hickman KA, Lourenco C, Redel C, Resetca D, Tamachi A, Tu WB, Penn LZ. MYC Deregulation in Primary Human Cancers. Genes (Basel) 2017;8:E151. [PMID: 28587062 DOI: 10.3390/genes8060151] [Cited by in Crossref: 146] [Cited by in F6Publishing: 107] [Article Influence: 36.5] [Reference Citation Analysis]
232 Pavlovic Z, Adams JJ, Blazer LL, Gakhal AK, Jarvik N, Steinhart Z, Robitaille M, Mascall K, Pan J, Angers S, Moffat J, Sidhu SS. A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties. MAbs. 2018;10:1157-1167. [PMID: 30183492 DOI: 10.1080/19420862.2018.1515565] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
233 Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010;138:2059-2072. [PMID: 20420946 DOI: 10.1053/j.gastro.2009.12.065] [Cited by in Crossref: 398] [Cited by in F6Publishing: 350] [Article Influence: 36.2] [Reference Citation Analysis]
234 Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS, Jarnicki AG, Winbanks CE, Newton IP, Meniel VS, Suzuki H, Stacker SA, Näthke IS, Tosh D, Huelsken J, Clarke AR, Heath JK, Sansom OJ, Ernst M. Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet 2010;6:e1000816. [PMID: 20084116 DOI: 10.1371/journal.pgen.1000816] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
235 Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR, Fearon ER. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell 2002;1:145-55. [PMID: 12086873 DOI: 10.1016/s1535-6108(02)00035-1] [Cited by in Crossref: 107] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
236 Chen Z, Venkatesan AM, Dehnhardt CM, Santos OD, Santos ED, Ayral-kaloustian S, Chen L, Geng Y, Arndt KT, Lucas J, Chaudhary I, Mansour TS. 2,4-Diamino-quinazolines as inhibitors of β-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer. Bioorganic & Medicinal Chemistry Letters 2009;19:4980-3. [DOI: 10.1016/j.bmcl.2009.07.070] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
237 Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22:1184-1193. [PMID: 11809809 DOI: 10.1128/mcb.22.4.1184-1193.2002] [Cited by in Crossref: 712] [Cited by in F6Publishing: 475] [Article Influence: 37.5] [Reference Citation Analysis]
238 Kühl SJ, Kühl M. On the role of Wnt/β-catenin signaling in stem cells. Biochim Biophys Acta. 2013;1830:2297-2306. [PMID: 22986148 DOI: 10.1016/j.bbagen.2012.08.010] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
239 Coster AD, Thorne CA, Wu LF, Altschuler SJ. Examining Crosstalk among Transforming Growth Factor β, Bone Morphogenetic Protein, and Wnt Pathways. J Biol Chem 2017;292:244-50. [PMID: 27895117 DOI: 10.1074/jbc.M116.759654] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
240 Liu Z, Sun R, Zhang X, Qiu B, Chen T, Li Z, Xu Y, Zhang Z. Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1. EBioMedicine 2019;45:181-91. [PMID: 31248836 DOI: 10.1016/j.ebiom.2019.06.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
241 Dehnhardt CM, Venkatesan AM, Chen Z, Ayral-kaloustian S, Dos Santos O, Delos Santos E, Curran K, Follettie MT, Diesl V, Lucas J, Geng Y, Dejoy SQ, Petersen R, Chaudhary I, Brooijmans N, Mansour TS, Arndt K, Chen L. Design and Synthesis of Novel Diaminoquinazolines with in Vivo Efficacy for β-Catenin/T-Cell Transcriptional Factor 4 Pathway Inhibition. J Med Chem 2010;53:897-910. [DOI: 10.1021/jm901370m] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
242 Hughes TA, Brady HJ. E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation. Biochem Biophys Res Commun 2005;329:1267-74. [PMID: 15766563 DOI: 10.1016/j.bbrc.2005.02.102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
243 Huang S, Fantini D, Merrill BJ, Bagchi S, Guzman G, Raychaudhuri P. DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer. Cancer Res 2017;77:6562-75. [PMID: 29021137 DOI: 10.1158/0008-5472.CAN-17-1570] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
244 Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi T. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell. 2012;149:1245-1256. [PMID: 22682247 DOI: 10.1016/j.cell.2012.05.002] [Cited by in Crossref: 552] [Cited by in F6Publishing: 487] [Article Influence: 61.3] [Reference Citation Analysis]
245 Goldsberry WN, Londoño A, Randall TD, Norian LA, Arend RC. A Review of the Role of Wnt in Cancer Immunomodulation. Cancers (Basel) 2019;11:E771. [PMID: 31167446 DOI: 10.3390/cancers11060771] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
246 Larraguibel J, Weiss AR, Pasula DJ, Dhaliwal RS, Kondra R, Van Raay TJ. Wnt ligand-dependent activation of the negative feedback regulator Nkd1. Mol Biol Cell 2015;26:2375-84. [PMID: 25904337 DOI: 10.1091/mbc.E14-12-1648] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
247 Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E. The way Wnt works: components and mechanism. Growth Factors. 2013;31:1-31. [PMID: 23256519 DOI: 10.3109/08977194.2012.752737] [Cited by in Crossref: 141] [Cited by in F6Publishing: 118] [Article Influence: 15.7] [Reference Citation Analysis]
248 Mahmoudi T, Li VS, Ng SS, Taouatas N, Vries RG, Mohammed S, Heck AJ, Clevers H. The kinase TNIK is an essential activator of Wnt target genes. EMBO J. 2009;28:3329-3340. [PMID: 19816403 DOI: 10.1038/emboj.2009.285] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.9] [Reference Citation Analysis]
249 Chesire DR, Isaacs WB. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor. Oncogene. 2002;21:8453-8469. [PMID: 12466965 DOI: 10.1038/sj.onc.1206049] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 5.9] [Reference Citation Analysis]
250 Lu Q, Jiang B, Lin C, Shan T. Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat. J Exp Clin Cancer Res 2008;27:26. [PMID: 18681964 DOI: 10.1186/1756-9966-27-26] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
251 Wu C, Luo K, Zhao F, Yin P, Song Y, Deng M, Huang J, Chen Y, Li L, Lee S, Kim J, Zhou Q, Tu X, Nowsheen S, Luo Q, Gao X, Lou Z, Liu Z, Yuan J. USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization. Cell Death Differ 2018;25:1855-69. [PMID: 29867130 DOI: 10.1038/s41418-018-0138-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
252 Liu J, Stevens J, Matsunami N, White RL. Targeted degradation of beta-catenin by chimeric F-box fusion proteins. Biochem Biophys Res Commun 2004;313:1023-9. [PMID: 14706645 DOI: 10.1016/j.bbrc.2003.12.035] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
253 Akaboshi S, Watanabe S, Hino Y, Sekita Y, Xi Y, Araki K, Yamamura K, Oshima M, Ito T, Baba H. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol. 2009;175:1675-1685. [PMID: 19729480 DOI: 10.2353/ajpath.2009.090069] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
254 Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui-Beltran A, Clement G, Lin YC, Okamoto J, Bravo DT, Jablons DM. Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int J Cancer 2007;121:1175-81. [PMID: 17534895 DOI: 10.1002/ijc.22848] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
255 Liu Z, Rebowe RE, Wang Z, Li Y, Wang Z, DePaolo JS, Guo J, Qian C, Liu W. KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer. Mol Cancer Res 2014;12:491-503. [PMID: 24413182 DOI: 10.1158/1541-7786.MCR-13-0418] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
256 Wang L, Li H, Chen Q, Zhu T, Zhu H, Zheng L. Wnt signaling stabilizes the DIXDC1 protein through decreased ubiquitin-dependent degradation. Cancer Science 2010;101:700-6. [DOI: 10.1111/j.1349-7006.2009.01448.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
257 Firestone AJ, Chen JK. Controlling destiny through chemistry: small-molecule regulators of cell fate. ACS Chem Biol 2010;5:15-34. [PMID: 20000447 DOI: 10.1021/cb900249y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
258 Nilbert M, Rambech E. Beta-catenin activation through mutation is rare in rectal cancer. Cancer Genet Cytogenet. 2001;128:43-45. [PMID: 11454429 DOI: 10.1016/s0165-4608(01)00397-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
259 Novellasdemunt L, Antas P, Li VS. Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. Am J Physiol Cell Physiol. 2015;309:C511-C521. [PMID: 26289750 DOI: 10.1152/ajpcell.00117.2015] [Cited by in Crossref: 182] [Cited by in F6Publishing: 160] [Article Influence: 30.3] [Reference Citation Analysis]
260 Ou CY, Kim JH, Yang CK, Stallcup MR. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells. J Biol Chem. 2009;284:20629-20637. [PMID: 19520846 DOI: 10.1074/jbc.M109.014332] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
261 Sun X, Suo J, Yan J. Immunotherapy in human colorectal cancer: Challenges and prospective. World J Gastroenterol. 2016;22:6362-6372. [PMID: 27605872 DOI: 10.3748/wjg.v22.i28.6362] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
262 DeRycke MS, Gunawardena S, Balcom JR, Pickart AM, Waltman LA, French AJ, McDonnell S, Riska SM, Fogarty ZC, Larson MC, Middha S, Eckloff BW, Asmann YW, Ferber MJ, Haile RW, Gallinger S, Clendenning M, Rosty C, Win AK, Buchanan DD, Hopper JL, Newcomb PA, Le Marchand L, Goode EL, Lindor NM, Thibodeau SN. Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Mol Genet Genomic Med 2017;5:553-69. [PMID: 28944238 DOI: 10.1002/mgg3.317] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
263 Kitazawa M, Hatta T, Ogawa K, Fukuda E, Goshima N, Natsume T. Determination of Rate-Limiting Factor for Formation of Beta-Catenin Destruction Complexes Using Absolute Protein Quantification. J Proteome Res 2017;16:3576-84. [PMID: 28810742 DOI: 10.1021/acs.jproteome.7b00305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
264 Liu D, Li L, Yang Y, Liu W, Wu J. The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population. Tumour Biol 2014;35:10987-91. [PMID: 25091576 DOI: 10.1007/s13277-014-2399-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
265 Peng Y, Zhang X, Feng X, Fan X, Jin Z. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer. Oncotarget 2017;8:14089-106. [PMID: 27793042 DOI: 10.18632/oncotarget.12923] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 16.0] [Reference Citation Analysis]
266 Tan S, Barker N. Epithelial stem cells and intestinal cancer. Semin Cancer Biol. 2015;32:40-53. [PMID: 24560652 DOI: 10.1016/j.semcancer.2014.02.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
267 Vincent JP, Kolahgar G, Gagliardi M, Piddini E. Steep differences in wingless signaling trigger Myc-independent competitive cell interactions. Dev Cell 2011;21:366-74. [PMID: 21839923 DOI: 10.1016/j.devcel.2011.06.021] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 8.6] [Reference Citation Analysis]
268 Xia J, Urabe K, Moroi Y, Koga T, Duan H, Li Y, Furue M. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. J Dermatol Sci. 2006;41:67-75. [PMID: 16378715 DOI: 10.1016/j.jdermsci.2005.09.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
269 Dzobo K, Thomford NE, Senthebane DA. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy. OMICS 2019;23:517-38. [PMID: 31613700 DOI: 10.1089/omi.2019.0147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
270 Enzo MV, Rastrelli M, Rossi CR, Hladnik U, Segat D. The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. Mol Cell Ther 2015;3:1. [PMID: 26056602 DOI: 10.1186/s40591-015-0038-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
271 Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene 2011;30:2633-43. [PMID: 21317929 DOI: 10.1038/onc.2010.632] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
272 Yanai K, Nakamura M, Akiyoshi T, Nagai S, Wada J, Koga K, Noshiro H, Nagai E, Tsuneyoshi M, Tanaka M, Katano M. Crosstalk of hedgehog and Wnt pathways in gastric cancer. Cancer Lett 2008;263:145-56. [PMID: 18243529 DOI: 10.1016/j.canlet.2007.12.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
273 Tian A, Benchabane H, Ahmed Y. Wingless/Wnt Signaling in Intestinal Development, Homeostasis, Regeneration and Tumorigenesis: A Drosophila Perspective. J Dev Biol 2018;6:E8. [PMID: 29615557 DOI: 10.3390/jdb6020008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
274 MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26. [PMID: 19619488 DOI: 10.1016/j.devcel] [Reference Citation Analysis]
275 Hu BR, Fairey AS, Madhav A, Yang D, Li M, Groshen S, Stephens C, Kim PH, Virk N, Wang L, Martin SE, Erho N, Davicioni E, Jenkins RB, Den RB, Xu T, Xu Y, Gill IS, Quinn DI, Goldkorn A. AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth. Prostate 2016;76:597-608. [PMID: 26771938 DOI: 10.1002/pros.23151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
276 Frei T, Cella F, Tedeschi F, Gutiérrez J, Stan GB, Khammash M, Siciliano V. Characterization and mitigation of gene expression burden in mammalian cells. Nat Commun 2020;11:4641. [PMID: 32934213 DOI: 10.1038/s41467-020-18392-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 17.0] [Reference Citation Analysis]
277 Umar S. Citrobacter Infection and Wnt signaling. Curr Colorectal Cancer Rep 2012;8. [PMID: 24358033 DOI: 10.1007/s11888-012-0143-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
278 Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer. 2002;34:255-268. [PMID: 12007186 DOI: 10.1002/gcc.10083] [Cited by in Crossref: 244] [Cited by in F6Publishing: 219] [Article Influence: 12.8] [Reference Citation Analysis]
279 Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 2001;11:547-53. [PMID: 11532397 DOI: 10.1016/s0959-437x(00)00231-8] [Cited by in Crossref: 411] [Cited by in F6Publishing: 149] [Article Influence: 20.6] [Reference Citation Analysis]
280 Guo P, Wang Y, Dai C, Tao C, Wu F, Xie X, Yu H, Zhu Q, Li J, Ye L, Yu F, Shan Y, Yu Z, Dhanasekaran R, Zheng R, Chen G. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma. Oncogene 2018;37:1220-36. [DOI: 10.1038/s41388-017-0017-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
281 Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev. 2005;26:898-915. [PMID: 16126938 DOI: 10.1210/er.2003-0034] [Cited by in Crossref: 257] [Cited by in F6Publishing: 263] [Article Influence: 16.1] [Reference Citation Analysis]
282 Lindvall C, Bu W, Williams BO, Li Y. Wnt Signaling, Stem Cells, and the Cellular Origin of Breast Cancer. Stem Cell Rev 2007;3:157-68. [DOI: 10.1007/s12015-007-0025-3] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
283 Morkel M, Huelsken J, Wakamiya M, Ding J, van de Wetering M, Clevers H, Taketo MM, Behringer RR, Shen MM, Birchmeier W. Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 2003;130:6283-94. [PMID: 14623818 DOI: 10.1242/dev.00859] [Cited by in Crossref: 124] [Cited by in F6Publishing: 122] [Article Influence: 7.3] [Reference Citation Analysis]
284 Lee PY, Chin SF, Low TY, Jamal R. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives. J Proteomics 2018;187:93-105. [PMID: 29953962 DOI: 10.1016/j.jprot.2018.06.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
285 MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26. [PMID: 19619488 DOI: 10.1016/j.devcel.2009.06.016s1534-5807(09)00257-3] [Reference Citation Analysis]
286 Xue X, Shah YM. In vitro organoid culture of primary mouse colon tumors. J Vis Exp. 2013;2001:e50210. [PMID: 23711911 DOI: 10.3791/50210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
287 Perucho M. Tumors with microsatellite instability: many mutations, targets and paradoxes. Oncogene 2003;22:2223-5. [DOI: 10.1038/sj.onc.1206580] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
288 Venkatachalam K, Vinayagam R, Arokia Vijaya Anand M, Isa NM, Ponnaiyan R. Biochemical and molecular aspects of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis: a review. Toxicol Res (Camb) 2020;9:2-18. [PMID: 32440334 DOI: 10.1093/toxres/tfaa004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
289 Nakamura I, Fernandez-Barrena MG, Ortiz-Ruiz MC, Almada LL, Hu C, Elsawa SF, Mills LD, Romecin PA, Gulaid KH, Moser CD. Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration. J Biol Chem. 2013;288:21389-21398. [PMID: 23740243 DOI: 10.1074/jbc.M112.443440] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
290 Muñoz-Bello JO, Olmedo-Nieva L, Castro-Muñoz LJ, Manzo-Merino J, Contreras-Paredes A, González-Espinosa C, López-Saavedra A, Lizano M. HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor. Int J Mol Sci 2018;19:E3153. [PMID: 30322153 DOI: 10.3390/ijms19103153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
291 Bustos VH, Ferrarese A, Venerando A, Marin O, Allende JE, Pinna LA. The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1. Proc Natl Acad Sci U S A 2006;103:19725-30. [PMID: 17172446 DOI: 10.1073/pnas.0609424104] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
292 Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, Macri E, Loda M, Appelman HD, Cho KR, Fearon ER. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol. 2001;159:2239-2248. [PMID: 11733373 DOI: 10.1016/s0002-9440(10)63074-x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 54] [Article Influence: 7.5] [Reference Citation Analysis]
293 Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W, Okamoto M, Matsumura M, Kawabe T, Shiratori Y. Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res. 2002;93:1213-1220. [PMID: 12460462 DOI: 10.1111/j.1349-7006.2002] [Reference Citation Analysis]
294 Mu Y, Xu Z, Contreras CI, McDaniel JS, Donly KJ, Chen S. Phenotype characterization and sequence analysis of BMP2 and BMP4 variants in two Mexican families with oligodontia. Genet Mol Res 2012;11:4110-20. [PMID: 23079991 DOI: 10.4238/2012.September.25.5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
295 Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH. Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum Pathol. 2009;40:58-64. [PMID: 18755497 DOI: 10.1016/j.humpath.2008.06.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
296 Peterlongo P, Howe LR, Radice P, Sala P, Hong YJ, Hong SI, Mitra N, Offit K, Ellis NA. Germline mutations of AXIN2 are not associated with nonsyndromic colorectal cancer. Hum Mutat. 2005;25:498-500. [PMID: 15841489 DOI: 10.1002/humu.20189] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
297 Yang Q, Feng M, Ma X, Li H, Xie W. Gene expression profile comparison between colorectal cancer and adjacent normal tissues. Oncol Lett 2017;14:6071-8. [PMID: 29113248 DOI: 10.3892/ol.2017.6915] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
298 Feigin ME, Malbon CC. OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling. Cell Signal 2008;20:949-57. [PMID: 18296023 DOI: 10.1016/j.cellsig.2008.01.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
299 Albuquerque C, Bakker ER, van Veelen W, Smits R. Colorectal cancers choosing sides. Biochim Biophys Acta 2011;1816:219-31. [PMID: 21855610 DOI: 10.1016/j.bbcan.2011.07.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
300 Domingo E, Espín E, Armengol M, Oliveira C, Pinto M, Duval A, Brennetot C, Seruca R, Hamelin R, Yamamoto H, Schwartz S Jr. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 2004;39:138-42. [PMID: 14695993 DOI: 10.1002/gcc.10310] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
301 Hu X, Shang M, Zhou J, Ye Y, Lu X, Tao C, Ying B, Wang L. Association of genetic variants in Wnt signaling pathway with tuberculosis in Chinese Han population. PLoS One 2014;9:e93841. [PMID: 24695522 DOI: 10.1371/journal.pone.0093841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
302 El-bchiri J, Buhard O, Penard-lacronique V, Thomas G, Hamelin R, Duval A. Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers. Human Molecular Genetics 2005;14:2435-42. [DOI: 10.1093/hmg/ddi245] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
303 Bregman H, Chakka N, Guzman-Perez A, Gunaydin H, Gu Y, Huang X, Berry V, Liu J, Teffera Y, Huang L, Egge B, Mullady EL, Schneider S, Andrews PS, Mishra A, Newcomb J, Serafino R, Strathdee CA, Turci SM, Wilson C, DiMauro EF. Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors. J Med Chem 2013;56:4320-42. [PMID: 23701517 DOI: 10.1021/jm4000038] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
304 Marra G, Jiricny J. DNA Mismatch Repair and Colon Cancer. In: Back N, Cohen IR, Kritchevsky D, Lajtha A, Paoletti R, Nigg EA, editors. Genome Instability in Cancer Development. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 85-123. [DOI: 10.1007/1-4020-3764-3_4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
305 Oosterveen T, Coudreuse DY, Yang PT, Fraser E, Bergsma J, Dale TC, Korswagen HC. Two functionally distinct Axin-like proteins regulate canonical Wnt signaling in C. elegans. Dev Biol 2007;308:438-48. [PMID: 17601533 DOI: 10.1016/j.ydbio.2007.05.043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
306 Crago AM, Chmielecki J, Rosenberg M, O'Connor R, Byrne C, Wilder FG, Thorn K, Agius P, Kuk D, Socci ND, Qin LX, Meyerson M, Hameed M, Singer S. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes Chromosomes Cancer 2015;54:606-15. [PMID: 26171757 DOI: 10.1002/gcc.22272] [Cited by in Crossref: 76] [Cited by in F6Publishing: 58] [Article Influence: 12.7] [Reference Citation Analysis]
307 Chia IV, Costantini F. Mouse axin and axin2/conductin proteins are functionally equivalent in vivo. Mol Cell Biol 2005;25:4371-6. [PMID: 15899843 DOI: 10.1128/MCB.25.11.4371-4376.2005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
308 Krishnadath KK, Wang KK. Molecular pathogenesis of Barrett esophagus: current evidence. Gastroenterol Clin North Am. 2015;44:233-247. [PMID: 26021192 DOI: 10.1016/j.gtc.2015.02.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
309 Izrailit J, Reedijk M. Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications. Cancer Letters 2012;317:115-26. [DOI: 10.1016/j.canlet.2011.11.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
310 Kulikova KV, Posvyatenko AV, Gnuchev NV, Georgiev GP, Kibardin AV, Larin SS. Nuclear β-catenin localization is not sufficient for canonical Wnt signaling activation in human melanoma cell lines. Mol Biol 2011;45:816-22. [DOI: 10.1134/s0026893311050098] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
311 Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010;138:2059-2072. [PMID: 20420946 DOI: 10.1053/j.gastro.2009.12.065s0016-5085(10)00170-8] [Reference Citation Analysis]
312 Zarkou V, Galaras A, Giakountis A, Hatzis P. Crosstalk mechanisms between the WNT signaling pathway and long non-coding RNAs. Noncoding RNA Res 2018;3:42-53. [PMID: 30159439 DOI: 10.1016/j.ncrna.2018.04.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
313 Ouko L, Ziegler TR, Gu LH, Eisenberg LM, Yang VW. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem 2004;279:26707-15. [PMID: 15084607 DOI: 10.1074/jbc.M402877200] [Cited by in Crossref: 73] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
314 Kretzschmar K, Clevers H. Wnt/β-catenin signaling in adult mammalian epithelial stem cells. Dev Biol 2017;428:273-82. [PMID: 28526587 DOI: 10.1016/j.ydbio.2017.05.015] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 19.3] [Reference Citation Analysis]
315 Lietman C, Wu B, Lechner S, Shinar A, Sehgal M, Rossomacha E, Datta P, Sharma A, Gandhi R, Kapoor M, Young PP. Inhibition of Wnt/β-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. JCI Insight 2018;3:96308. [PMID: 29415892 DOI: 10.1172/jci.insight.96308] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 17.0] [Reference Citation Analysis]
316 Kendall JJ, Chaney KE, Patel AV, Rizvi TA, Largaespada DA, Ratner N. CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin. Oncotarget 2016;7:53191-203. [PMID: 27448963 DOI: 10.18632/oncotarget.10668] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
317 Valkenburg KC, Graveel CR, Zylstra-Diegel CR, Zhong Z, Williams BO. Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers (Basel) 2011;3:2050-79. [PMID: 24212796 DOI: 10.3390/cancers3022050] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
318 Ge X, Jin Q, Zhang F, Yan T, Zhai Q. PCAF acetylates {beta}-catenin and improves its stability. Mol Biol Cell 2009;20:419-27. [PMID: 18987336 DOI: 10.1091/mbc.e08-08-0792] [Cited by in Crossref: 82] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
319 Tseng RC, Lin RK, Wen CK, Tseng C, Hsu HS, Hsu WH, Wang YC. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. Oncogene 2008;27:4488-96. [PMID: 18372914 DOI: 10.1038/onc.2008.83] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
320 Couch FJ, Wang X, Bamlet WR, de Andrade M, Petersen GM, McWilliams RR. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. Cancer Epidemiol Biomarkers Prev 2010;19:251-7. [PMID: 20056645 DOI: 10.1158/1055-9965.EPI-09-0629] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
321 Sawyer EJ, Hanby AM, Rowan AJ, Gillett CE, Thomas RE, Poulsom R, Lakhani SR, Ellis IO, Ellis P, Tomlinson IPM. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol 2002;196:437-44. [DOI: 10.1002/path.1067] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
322 Gao T, Yu L, Fang Z, Liu J, Bai C, Li S, Xue R, Zhang L, Tan Z, Fan Z. KIF18B promotes tumor progression in osteosarcoma by activating β-catenin. Cancer Biol Med 2020;17:371-86. [PMID: 32587775 DOI: 10.20892/j.issn.2095-3941.2019.0452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
323 Wong NA, Pignatelli M. Beta-catenin--a linchpin in colorectal carcinogenesis? Am J Pathol. 2002;160:389-401. [PMID: 11839557 DOI: 10.1016/s0002-9440(10)64856-0] [Cited by in Crossref: 234] [Cited by in F6Publishing: 88] [Article Influence: 12.3] [Reference Citation Analysis]
324 Galluzzi L, Spranger S, Fuchs E, López-Soto A. WNT Signaling in Cancer Immunosurveillance. Trends Cell Biol 2019;29:44-65. [PMID: 30220580 DOI: 10.1016/j.tcb.2018.08.005] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 22.3] [Reference Citation Analysis]
325 van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis A, Tjon-pon-fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells. Cell 2002;111:241-50. [DOI: 10.1016/s0092-8674(02)01014-0] [Cited by in Crossref: 1491] [Cited by in F6Publishing: 718] [Article Influence: 78.5] [Reference Citation Analysis]
326 Fre S, Vignjevic D, Schoumacher M, Duffy SL, Janssen KP, Robine S, Louvard D. Epithelial morphogenesis and intestinal cancer: new insights in signaling mechanisms. Adv Cancer Res 2008;100:85-111. [PMID: 18620093 DOI: 10.1016/S0065-230X(08)00003-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]